| There’s still time to register for our free webinar, discussing the Drug Enforcement Administration (DEA)’s quiet acknowledgement of the federal legality of cannabis seeds in 2022, and how this news has created a state-federal disconnect.
Historically, growers and breeders have faced difficulties selling and acquiring genetics under stringent regulations in some states, and a “don’t ask, don’t tell” policy in others.
Today, with this clarification from the DEA, there’s confusion over whether federal or state law takes precedent going forward.
We’ll be going live tomorrow (Feb. 1) at 2 p.m. ET, with the following legal and operational experts. Gain insights from: Shane Pennington, counsel of Vicente Sederberg LLP, who received the clarifying letter from the DEA in response to his inquiry on seed legalities. Jay Wexler, professor of law at Boston University, who has a focus in cannabis as well as constitutional law. Rick Campanella (MrSoul), the CEO of Brothers Grimm Seeds, which recently battled with the USPS over confiscated seeds and won. Tom Wilson, owner of MoneyTree Genetics, which has opened a retail storefront selling seeds in Chicago. We’ll also be taking your questions, so don’t miss the opportunity to join us live to better understand one of the most important and complicated industry topics of the year.
|
